IMPACT TB : Implementing proven community-based active tuberculosis case finding interventions in Vietnam and Nepal.
Early identification and treatment of cases is key to control of all epidemic diseases and tuberculosis (TB) is no exception. Despite availability of effective treatment for TB for over 50 years, the number of people suffering with TB in low and middle income countries remains extremely high, with 2 million people dying of TB every year. CAHRD at LSTM has been awarded 5 million euros for a consortium to scale-up active case finding for tuberculosis in Vietnam and Nepal (PI: Dr Maxine Caws). These two countries both have a very high incidence of TB with limited health resources and need therefore to allocate these resources in the most efficient way to have maximum impact on the disease epidemic.
The project is funded under the European Union Horizon 2020 framework call ‘Implementation research for scaling-up of evidence based innovations and good practice in Europe and low- and middle-income countries’ and will start in January 2017 for three years.
LSTM is working with local implementing partners the Birat-Nepal Medical Trust in Nepal and Friends for International TB Relief in Vietnam to expand their successful active case finding models for tuberculosis while also generating evidence for national and international policy makers on costs and yields of different strategies from both a health system and patient perspective in partnership with Karolinska Institute, Sweden and KNCV, Netherlands.